Dr. David Porter Johnson, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 386 Bayview Dr Ne, St Petersburg, FL 33704 Phone: 727-398-6661 Fax: 727-319-1057 |
Salim N Hamade, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 900 Carillon Pkwy, Suite 112, St Petersburg, FL 33716 Phone: 727-233-0111 Fax: 727-231-8100 |
Dr. Brian W Elliott, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3251 3rd Ave N, St Petersburg, FL 33713 Phone: 727-321-3854 Fax: 727-327-7670 |
Dr. Mobola T Campbell, M.D. MPH Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1839 Central Ave., St Petersburg, FL 33713 Phone: 727-322-1054 Fax: 727-821-7213 |
Joseph Blackwell Paruolo, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1839 Central Ave, St Petersburg, FL 33713 Phone: 727-322-1054 Fax: 727-821-7213 |
Mingquan Tongbhakdee Suksanong, M.D. Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1752 Mlk Jr St N, St Petersburg, FL 33704 Phone: 727-823-7224 Fax: 727-489-9486 |
News Archive
The Equal Employment Opportunity Commission on Thursday in a U.S. District Court in New York City filed a lawsuit against Bloomberg L.P. - the financial and media company founded by Mayor Michael Bloomberg - saying the company discriminated against three female employees after they became pregnant and took maternity leave, the New York Times reports.
H. Lundbeck A/S (Lundbeck) and Merck, known outside the United States and Canada as MSD, today announced a commercialization agreement for SYCREST (asenapine) sublingual tablets (5 mg, 10 mg). Under the terms of the agreement, Lundbeck will pay an undisclosed fee as well as product supply payments in exchange for exclusive commercial rights to SYCREST in all markets outside the United States, China and Japan. Lundbeck expects to launch SYCREST in the European Union (EU), where it is already approved, at the beginning of 2011.
Sigma-Aldrich Corporation today announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's arrayed lentiviral CRISPR library. The library will be the first of its kind, providing researchers with a collection of individual clones designed to knock out every known human and mouse protein-coding gene using the CRISPR system.
Scientists have used a new method to map the response of every salmonella gene to conditions in the human body, providing new insight into how the bacteria triggers infection.
› Verified 8 days ago